How do you manage adjuvant endocrine therapy for microinvasive HR-positive disease measuring >=1 mm in extension?
Answer from: Medical Oncologist at Academic Institution
I manage unifocal T1mi disease similar to ER+ DCIS by discussing 5 years of endocrine therapy. The treatment is not so much to avert metastatic recurrence rather it is to lower the risk of a subsequent breast cancer in any remaining natural breast tissue. If they had bilateral mastectomies then I do...
Comments
Medical Oncologist at Trinity Health IHA Medical Group, Hematology Oncology Thank you for the comments.
I'm wondering if you ...
Medical Oncologist at NYU Langone Medical Center My understanding is that the chance of micro-metas...
Medical Oncologist at H Lee Moffitt Cancer Center, University of South Florida Correct, you don't add up the foci. Multifocal mic...
Thank you for the comments. I'm wondering if you ...
My understanding is that the chance of micro-metas...
Correct, you don't add up the foci. Multifocal mic...